| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/14/2008 | WO2008079342A3 Composition of and method for preparing orally disintegrating tablets |
| 08/14/2008 | WO2008077939A3 Duloxetine composition |
| 08/14/2008 | WO2008076436A3 Systems and methods for a pregnancy monitoring device |
| 08/14/2008 | WO2008075333A3 Edible compositions for preventing hair loss |
| 08/14/2008 | WO2008075320A3 Antilipidemic pharmaceutical compositions and process for preparation thereof |
| 08/14/2008 | WO2008072206A3 Composition comprising pyrithione or a polyvalent metal salt of a pyrithione and furametpyr |
| 08/14/2008 | WO2008068217A3 Pharmaceutical composition comprising a coated hmg-coa reductase inhibitor and an inhibitor of the renin-angiotensin system |
| 08/14/2008 | WO2008067060A3 Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue |
| 08/14/2008 | WO2008066778A9 Decontaminant edible product, methods of production and uses thereof |
| 08/14/2008 | WO2008066716A3 Film-coated solid dosage form |
| 08/14/2008 | WO2008062446A3 An extended release composition of levetiracetam, which exhibits no adverse food effect |
| 08/14/2008 | WO2008062426A3 Formulation of benzazepine derivatives |
| 08/14/2008 | WO2008048874A3 Method of weight control employing chewing gum |
| 08/14/2008 | WO2008045563A9 Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates |
| 08/14/2008 | WO2008036798A3 Methods and systems of delivering medication via inhalation |
| 08/14/2008 | WO2008023390B1 Modified release pharmaceutical composition of bupropion hydrochloride |
| 08/14/2008 | WO2008021908A3 Multistage delivery of active agents |
| 08/14/2008 | WO2008021113A3 Transdermal methods and systems for treating alzheimer's disease |
| 08/14/2008 | WO2008020420A3 Compositions comprising calcium citrate malate and methods for making the same |
| 08/14/2008 | WO2007146293A3 Improved composition and method for taste masking |
| 08/14/2008 | WO2007110694A3 Gelling hydrophobic injectable polymer compositions |
| 08/14/2008 | WO2007087188A8 Taste-masked tablets and granules |
| 08/14/2008 | WO2007076328A3 Rna interference mediated inhibition of hepatitis c virus |
| 08/14/2008 | WO2007066189A3 Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
| 08/14/2008 | WO2006080951A8 Targeted and high density drug loaded polymeric materials |
| 08/14/2008 | WO2006002253A3 Native soft tissue matrix for therapeutic applications |
| 08/14/2008 | US20080195083 Implantable bolus injector |
| 08/14/2008 | US20080195080 Valved delivery device and method of delivering a substance to a patient |
| 08/14/2008 | US20080195033 Method of Delivery of Therapeutic Metal Ions, Alloys and Salts |
| 08/14/2008 | US20080194687 particle obtained by granulating 1-aminomethyl-cyclohexane-acetic acid with polyethylene glycol; antiepileptic agents |
| 08/14/2008 | US20080194676 Formulations for oral administration of cromolyn sodium |
| 08/14/2008 | US20080194671 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 08/14/2008 | US20080194469 Biodrug such as eptifibatide with blend of a hydrolyzable hydrophobic polymer containing diphenolic tyrosine monomer such as poly(desaminotyrosyltyrosine hexyl ester adipate (Poly(DTH adipate)), and another less hydrophobic hydrolyzable polymer that degrades to form acidic groups, releasing the biodrug |
| 08/14/2008 | US20080193632 Continuous Feed Tablet Coating System |
| 08/14/2008 | US20080193548 Suspension of micronized powder of, non-steroidal anti-inflammatory; enolcarboxamide acid, meloxicam; dispersed in polysaccharide polymer of carrageenans, xanthans, guars, alginic acid derivatives, silicon oxide powder |
| 08/14/2008 | US20080193547 Targeted delivery of drugs; nanodevices allow lower dosage for minimum inhibitory concentration; sandwich structure protects active ingredient to avoid immune reactions; incorporate paramagnetic ions, metals as diagnostic contrast agents for Magnetic Resonance Imaging |
| 08/14/2008 | US20080193546 Solid dose delivery vehicle and methods of making same |
| 08/14/2008 | US20080193545 Use of Glycerol Dipalmitostearate for Improving the Bioavailability of Protein Active Ingredients in Subcutaneous or Intramuscular Injectable Formulations |
| 08/14/2008 | US20080193544 Taste Masked Dosage Form Containing Roflumilast |
| 08/14/2008 | US20080193543 Oral dosage of microparticle metallomucoadhesive or ferromagnetic or superparamagnetic formulations for enhanced delivery of therapeutic, prophylactic, diagnostic agents to lymphatic capillaries; site-direct and retain in gastrointestinal tract |
| 08/14/2008 | US20080193542 Ziprasidone mesylate or ziprasidone hydrochloride; nanoparticles less than 2000 nm; carrier; two surface stabilizers; crystallization inhibitors; polyvinylpyrrolidone, Pluronic surfactants; psychosis, schizophrenia; administration via intramuscular or subcutaneous injection |
| 08/14/2008 | US20080193541 Particulate aqueous system for the preparation of a formulation for the treatment of adipose diseases |
| 08/14/2008 | US20080193540 Solid, Oral Drug Form Which Has Been Designed to Prevent Misuse |
| 08/14/2008 | US20080193539 Novel Stabilized Carotenoid Compositions |
| 08/14/2008 | US20080193538 Reaction product of hyaluronic acid and a phosphatidyl ethanolamine; biocompatibility and bio-safety; formed or molded to shape used to treat a knee joint; prevent accretion of a tissue after an operation; keep skin wet |
| 08/14/2008 | US20080193537 Morphine Sulfate Formulations |
| 08/14/2008 | US20080193536 Crosslinked polymeric network; cardiomyocytes, myocytes, hepatocytes, keratinocytes, melanocytes, neurons, astrocytes, stem cells are encapsulated; carbohydrate natural polymer, hyaluronic acid, alginate, collagen; physical, thermal, photo crosslinking mechanism; tissue engineering applications |
| 08/14/2008 | US20080193535 High speed dissolving dosage form; administering to mucous membrane;matrix containing gelatin, starch and mannitol |
| 08/14/2008 | US20080193534 Process |
| 08/14/2008 | US20080193533 Hydroxypropyl methyl cellulose, gum arabic, polyvinyl pyrrolidone, polyvinyl alcohol, pullulan ; tablet having middle layer between film layer of inner core and sugar coating layer of outer core has higher impact strength; sprayer employing two liquid feed pumps |
| 08/14/2008 | US20080193532 Antibiotic, colloidal silicon dioxide, povidone, silicified microcrystalline cellulose, croscarmellose sodium, magnesium stearate and a coating, Cmax is reached in less than five hours; tuberculosis |
| 08/14/2008 | US20080193531 Proton pump inhibitor, omeprazole, hydroxyomeprazole, esomeprazole, tenatoprazole, lansoprazole; H2 blocker, cimetidine, famotidine, nizatidine, ranitidine; formic, acetic, propionic acid; vitamin C, vitamin A, vitamin E; calcium, chromium, copper minerals; enteric coated; tablet, pill, powder, capsules |
| 08/14/2008 | US20080193530 Use of ranolazine for the treatment of non-coronary microvascular diseases |
| 08/14/2008 | US20080193529 Free-flowing, cohesive tableting powder for direct compressed tablet; DPP-IV inhibitor and glitazone, in unit dosage form; acceptable dissolution profile; acceptable degrees of hardness, resistance to chipping, short disintegration time |
| 08/14/2008 | US20080193528 Bosentan; excipients, filler, lubricant, disintegrant, acidifying agent, flavouring, sweetening; endothelin receptor inhibitor; pulmonary arterial hypertension |
| 08/14/2008 | US20080193527 Pharmaceutical compositions containing quetiapine fumarate |
| 08/14/2008 | US20080193526 Pharmaceutical Compositions Useful in the Treatment of Pain |
| 08/14/2008 | US20080193525 Potassium-magnesium citrate as a surrogate of the dash diet in managing hypertension |
| 08/14/2008 | US20080193524 Extended Release Venlafaxine Compositions |
| 08/14/2008 | US20080193523 Composition |
| 08/14/2008 | US20080193522 Use of Polymer Mixtures For the Production of Coated Pharmaceutical Formulations and Pharmaceutical Formulation With Mixed Polymeric Coating |
| 08/14/2008 | US20080193521 Hyperphosphatemia in chronic kidney disease or end-stage renal disease patients; nutritional supplements |
| 08/14/2008 | US20080193520 Method for the Gentle Production of Ultrafine Particle Suspensions and Ultrafine Particles and the Use Thereof |
| 08/14/2008 | US20080193519 An efflux pump inhibitor (2S)-2-(naphthyl-1-sulphonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid or the ethyl ester and a surfactant; improved intestinal absorption when orally administered |
| 08/14/2008 | US20080193518 3-[2-(3-tert-Butyl-ureido)-3,3-dimethyl-butyryl]-6,6-dimethyl-3-aza-bicyclo[3.1.0]hexane-2-carboxylic acid (2-carbamoyl-1-cyclobutylmethyl-2-oxo-ethyl)-amide; Solvent-anti-solvent precipitation; hepatitis C virus protease inhibitors |
| 08/14/2008 | US20080193517 Polymer Conjugates of K-252A and Derivatives Thereof |
| 08/14/2008 | US20080193516 Oxygen-carrying blood substitute preparations |
| 08/14/2008 | US20080193515 Overexpression of Wnt ligands and treatment of lytic bone diseases |
| 08/14/2008 | US20080193514 Liposomes comprised of cationic lipids, amphiphilic glycerophospholipid having a saturated fatty acid moiety and an unsaturated fatty acid moiety, and an active ingredient; improved bioavailability through transdermal administration of high water-soluble substances |
| 08/14/2008 | US20080193513 Dried Formulations of Nanoparticle-Coated Capsules |
| 08/14/2008 | US20080193512 Drug Carrier and Drug Carrier Kit for Inhibiting Fibrosis |
| 08/14/2008 | US20080193511 Homogenizing a lipid with an aqueous component or by incorporating compounds in preformed lipid-based nanoparticles; milder and safer than high pressure homogenization |
| 08/14/2008 | US20080193510 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 08/14/2008 | US20080193509 Liposome Preparation Containing Slightly Water-Soluble Camptothecin |
| 08/14/2008 | US20080193508 Local anti-infective agent for treatment of nail fungal infections |
| 08/14/2008 | US20080193507 Wound Healing Profile |
| 08/14/2008 | US20080193506 Tooth Cleaning kit Comprising At Least One Set Of Chewing Gum Pieces |
| 08/14/2008 | US20080193504 After cataract surgery; an intraocular lens implant coated with a p38 kinase inhibitor of SB203580 or SB202190, an ERK kinase inhibitor of U0126 or PD98059, or a Src family kinase inhibitor of 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine, SK1606 or SU6656; extended release formulations |
| 08/14/2008 | US20080193503 Melt extrusion of a mixture of memantine and biodegradable glycolic acid-lactic acid copolymer to make a sustained release implant to last for one week; glaucoma and proliferative vitreoretinopathy; angiogenesis inhibition |
| 08/14/2008 | US20080193502 Memantine intravitreal implants |
| 08/14/2008 | US20080193501 Synergistic; proliferative agents for bone and nervous tissue; can also include an antiinflammatory agent to treat rheumatoid or osteoarthritis; time-release formulations in dosage forms of solutions, gels, pastes or putties |
| 08/14/2008 | US20080193500 Aggrecan; collagen; heteropolysaccharide in extracellular matrix |
| 08/14/2008 | US20080193499 Inosine-monophosphate dehydrogenase inhibitor, clotrimazole, fluconazole, trifluridine, danazol, and asparaginase; sustained release; kits |
| 08/14/2008 | US20080193492 For vaginal dryness |
| 08/14/2008 | US20080193491 Diaminooxidase-Containing Pharmaceutical Compositions |
| 08/14/2008 | US20080193490 Use of Carbon Nanotube for Drug Delivery |
| 08/14/2008 | US20080193425 Methods for administering fgf18 |
| 08/14/2008 | US20080193415 HSA-free formulations of interferon-beta |
| 08/14/2008 | US20080193385 Compositions and methods for treating neuropathy |
| 08/14/2008 | US20080193383 administering delta receptor angonists such as diarylmethyl piperazine and diarylmethyl piperidine compounds; side effect reduction of anesthetics, barbiturates and analgesics |
| 08/14/2008 | US20080193375 Lung cancer-targeted peptides and applications thereof |
| 08/14/2008 | US20080193374 a solution comprising alpha ray emitters and chemotherapeutic agents, encapsulated in lipids, used as anticarcinogenic agents |
| 08/14/2008 | US20080193372 Efficacy and Safety of Targeted Particulate Agents with Decoy Systems |
| 08/14/2008 | US20080191581 Devices for intrabody delivery of molecules and systems and methods utilizing same |
| 08/14/2008 | DE102007007307A1 Fließfähige Gelatinezusammensetzung Flowable gelatin composition |
| 08/14/2008 | CA2689675A1 Bioceramic implants having bioactive substance |
| 08/14/2008 | CA2677838A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 08/14/2008 | CA2677631A1 Olopatadine formulations for topical nasal administration |
| 08/14/2008 | CA2677623A1 A dosage form containing two or more active pharmaceutical ingredients in different physical forms |
| 08/14/2008 | CA2677498A1 Polymer formulations for delivery of bioactive agents |